An apparatus for treating obesity of a patient having a stomach with a food cavity. The apparatus comprising a volume filling device adapted to be at least substantially invaginated by a stomach wall portion of the patient with the outer surface of the volume filling device resting against the stomach wall, such that the volume of the food cavity is reduced in size by a volume substantially exceeding the volume of the volume filling device. The apparatus further comprises at least one adjustable stretching device adapted to be at least substantially invaginated by a stomach wall portion of the patient with the outer surface of the stretching device resting against the stomach wall and adapted to stretch a portion of stomach wall, and a fluid connection device interconnecting the volume filling device and the stretching device.

An intestinal device, or a non-constrictive cuff, is configured for placement around an intestine. In the closed position the non-constrictive cuff is configured to be around at least part or all of an intestine, wherein the non-constrictive cuff does not constrict the portion of the intestine when deployed. A first intestinal device can be deployed for placement around a portion of an intestine, wherein a proximal end of the first intestinal device is configured to longitudinally overlap a distal end of a second intestinal device when disposed around an intestine. A method of use for a first intestinal device or non-constrictive cuff is also disclosed.

A sphincter assist device includes a plurality of interconnected and adjacent links which define a ring. Each link includes a body section and a latch cam. The body section includes a first set of side beams and a first set of snap arms. The latch cam includes a post extending from the body section and a cam disposed at an end portion of the post. The cam is engagable with the first set of snap arms of an adjacent link. Translation of the cam displaces the first set of snap arms and the first set of side beams to transition the sphincter assist device between open and closed configurations. The first set of snap arms, in combination with the first set of side beams, exert a positive non-linear force profile on the cam, thus defining a non-linear force profile of the sphincter assist device between the open and closed configurations.

An volume filling device for treatment of obesity is placed outside the stomach wall of the patient to reduce the inner volume of the stomach, thereby affecting the patient's appetite. By providing the volume filling device outside the stomach wall, contact with stomach acids is avoided, thereby increasing the life of the device.

A medical device may include an implantable device for treating a body tissue structure. The implantable device may include a wire structure which may include a wave pattern. The wire structure may be elastic so as to provide a pressure around the body tissue structure such that the pressure may change with movement of the body tissue structure.

A method for performing a sleeve gastrectomy includes providing a first medical device including a tube for insertion into an interior of a stomach, the tube having a proximal end and a distal end, and a shaping portion positioned at the distal end of the tube, providing an inflation lumen, and providing a second medical device, the second medical device being a stapler or clamp positioned externally on the stomach laterally adjacent to the first medical device. The method also includes introducing positive pressure into the stomach via the inflation lumen, defining a resection line for the sleeve gastrectomy, and clamping the stomach using the second medical device. The resection line is defined at least partially by the position of the second medical device relative to the first medical device when a predetermined positive pressure range is provided via the inflation lumen.

An apparatus for the treatment of acid reflux disease comprising two or more movement restriction device segments adapted to be movement restriction device of a controlled size. The movement restriction device can at least partly be invaginated by a patient's stomach fundus wall. A substantial part of the outer surface of the movement restriction device is adapted to rest against the stomach wall without injuring the latter in a position between the patient's diaphragm and at least a portion of the lower part of the invaginated stomach fundus wall, such that movement of the cardiac notch of the patient's stomach towards the patient's diaphragm is restricted, to thereby prevent the cardia from sliding through the patient's diaphragm opening into the patient's thorax, so as to maintain the supporting pressure against the patient's cardia sphincter muscle exerted from the patient's abdomen.

A method is used to reduce a volume of a stomach of a patient. The method includes inverting a portion of a stomach wall to thereby create an inverted portion. An expandable member is positioned adjacent to the outer surface of the inverted portion. The expandable member is expanded to thereby expand the inverted portion. The expanded expandable member has a first outer diameter. A base region of the inverted portion is cinched to thereby capture the expanded expandable member in the expanded inverted portion. The expanded expandable member has a first outer diameter. Expanding and cinching provide a cinch diameter to first outer diameter ratio from approximately 0.5:1 to approximately 0.9:1.

A gastroscopic method and instrument for treating obesity of a patient, using a device adapted to stretch a part of the stomach wall of said patient. The method comprises the steps of: inserting the device into the stomach through the esophagus, placing the device in contact with the stomach wall, and fixating the device to the stomach wall such that the device can stretch a part of the stomach wall.

A biocompatible implant for a method of treating a reflux disease in a patient by preventing the cardia sphincter from sliding through the patient's diaphragm hiatus opening into the patient's thorax, so as to maintain a pressure support from the patient's abdomen that supports the patient's cardia sphincter. The biocompatible implant has a rigid shape, a circumference of at least 15 mm and is configured to be introduced into the patent's abdomen through a trocar, be fully invaginatable in the patient's fundus wall, and function as an implantable movement restricting device preventing the cardia sphincter from sliding through the patient's diaphragm, when implanted.